Post on 14-Nov-2015
description
RESEARCH ETHICS IN MEDICAL SCIENCES
Ngatidjan
Department of Pharmacology and Therapy FoM UGM
Medical and Health Research Ethics Committee
Faculty of Medicine, Universitas Gadjah Mada RSUP Dr. Sardjito
Ngatidjan 1 RESEARCH ETHICS
Biomedical research :
pharmaceutics,
medical devices,
radiation and imaging,
surgical procedures,
medical records,
biological samples,
epidemiological,
social and psychological.
(is not just basic medical sciences)
RESEARCH ON MEDICAL SCIENCES
(Loedin, 2004) Ngatidjan 2 RESEARCH ETHICS
BIOMEDICAL RESEARCH :
Animal, population,
individually,
isolated cell, tissue / organ,
Microorganism, diseases, biological weapon etc.
Human, population,
individually,
isolated cell, tissue / organ.
have to be clear on ethical aspect why? Ngatidjan 3 RESEARCH ETHICS
Research in Biomedical, Clinic and PH
May involves :
Animals (healthy or artificially sick),
Human (healthy or getting sick),
Isolated cells, tissues, organs or other body components,
(from animals or human),
Groups of people or community.
Ngatidjan 4 RESEARCH ETHICS
5 RESEARCH ETHICS Ngatidjan
STUDY ON HUMAN
Experimental study give treatment / intervention
food, drug, devices, inflict certain condition
Non-experimental study case control
cohort
cross sectional
survey
(observation or interview)
explore things in subject right
ETHICAL BASIS
of studies on human
Ngatidjan 6 RESEARCH ETHICS
1. Before 19 century
therapy, empirical based use the most effective.
2. Since 19 century therapy based on scientific methods scientific based therapy, ethical scandal ethical aspect?
3. Scandals Tuskegee scandal poorly syphilis patient
NAZI scandal captured subject of study.
Nuremberg code (1947),
Universal declaration of human right (UN 1948),
Historical background
Ngatidjan 7 RESEARCH ETHICS
1. Tuskegee scandal a study conducted by Tuskegee Institute (Alabama 1930 1972) in Mason country (82% of residence were black and poor; 36% of them
were suffering from syphilis)
the patients did not receive any medical treatment at all although penicillin
was available (the study was to know the course of the disease).
the scandal was discovered by a journalist, Jean Heller.
the study was then stopped by government authority without any trial.
2. Nazi (Nuremberg) scandal Nuremberg doctor trial on captured people as the subjects.
the study was discovered in correlation with Nuremberg military tribunal.
ethical basis Nuremberg code
History ethics?:
Ngatidjan 8 RESEARCH ETHICS
NUREMBERG CODE 1947
Voluntary.
Must have fruitful result.
Based on the result on animal experimentation.
As to avoid unnecessary physical or mental suffering.
Not an life-death harmful result.
Degree of risk should never exceed the humanitarian.
Proper and adequate facilities.
Scientifically qualified researcher.
Subject may withdrawn freely from the study.
Experimentation may be stopped anytime if harmful result observed.
Ngatidjan 9 RESEARCH ETHICS
STUDY ON HUMAN
Experimental study give treatment / intervention food, drug, inflict certain condition
Non-experimental study case control, cohort, cross sectional,
survey
(observation or interview)
explore subject right
Ethical Consideration
Ngatidjan 10 RESEARCH ETHICS
ETHICAL BASED OF A RESEARCH
1. Reasonable ( scientific based),
2. Managable feasible,
3. Scientific merit,
4. Social merit (beneficence),
5. Competence,
6. Subject welfare,
7. Do no harm.
Ngatidjan 11 RESEARCH ETHICS
SIENTIFIC BASED
1. Reason (background),
2. Aims of the study,
3. Design (appropriate design),
4. Subject criteria (inclusive or exclusive criteria),
5. Sample size (the reasonable number of subject),
6. Randomization.
Ngatidjan 12 RESEARCH ETHICS
SIENTIFIC BASED
7. Data collecting (methods, procedure, etc.).
8. Data storing.
9. Data analysis.
10. Endpoint of the study
primarily,
secondary.
11. The length of time for the study.
12. Reporting publication.
Ngatidjan 13 RESEARCH ETHICS
ETHICAL BASED OF A RESEARCH
1. Reasonable ( scientific based),
2. Managable feasible,
3. Scientific merit,
4. Social merit (beneficence),
5. Competence,
6. Subject welfare,
7. Do no harm.
Ngatidjan 14 RESEARCH ETHICS
BASIC PRINCIPLES OF ETHICS
Respect for person,
Justice,
Human right,
Confidential,
Beneficence,
Non malfeasance.
Ngatidjan 15 RESEARCH ETHICS
BASIC PRINCIPLES OF ETHICS
1. Respect for person Respect for person as human (humanity)
Respect for autonomy self determination
Respect for the right
2. Justice treat everyone in the same manner according to
morally right and proper, dignity and their right.
randomization is an example.
balance of the right and responsibility Ngatidjan 16 RESEARCH ETHICS
3. INFORMED CONSENT
Information process
Comprehension
Volunteerness to join consent
Ngatidjan 17 RESEARCH ETHICS
3. INFORMED CONSENT
Informed having information
an information process must happened
Consent to give assent or approval
compliance in or approval of what is done
or proposed by another
agreement as to action or opinion
Volunteerness Ngatidjan 18 RESEARCH ETHICS
3. INFORMED CONSENT
a set of subject statement consists of :
the volunteerness to joint in a study
after having informations of a study, including :
the procedure of the study
the risk or any uncomfortable condition may occur
the advantage of the study
any alternative therapy can be given
person can be contacted in an emergency condition
the possibility of stop joining in the study Ngatidjan 19 RESEARCH ETHICS
3. INFORMED CONSENT
Sufficient information about the study (research)
aims of the study procedure benefit risk any alternative (if intervention applied) contact person the possibility of stop in joining participating
comprehension Ngatidjan 20 RESEARCH ETHICS
3. INFORMED CONSENT
Volunteerness
pressure free free from the following things :
give, reward, present etc. no inducement participations
status (student from teacher, soldier from commander)
threat (refuse to joint will get bad mark, will not be serviced)
fear (fear about future live if refuse to joint into the study)
consent or willing to participate in the study
Ngatidjan 21 RESEARCH ETHICS
individual consent
(in developed community, urban area).
community consent
(in underdeveloped community, and may
represented by key person).
3. INFORMED CONSENT
Ngatidjan 22 RESEARCH ETHICS
3. INFORMED CONSENT
Expressed orally
written
Implied or tacit (silent, understanding each other)
normal or constructive consent
emergency consent
(consent in an emergency situation)
Ngatidjan 23 RESEARCH ETHICS
4. CONFIDENTIAL
Information data, sample / materials have to be kept as a screed.
selective disclosure of information.
The use of data or sample as the purposes stated or the aims of the study
Respondent identity respondent's identity have to be transformed
to identity number (respondent`s number)
Ngatidjan 24 RESEARCH ETHICS
Client data is confident
- be ware about data handling and storing.
is it unlinked or linked information.
linked information anonymous code.
written or verbal interview (recorded).
do not give any chance to trace certain
(interesting) information
4. CONFIDENTIAL
Ngatidjan 25 RESEARCH ETHICS
Maximizing benefit, inform to subject about the benefit of the study.
coordinate with relatives to maximize the benefit.
accommodate the need of the subject ( patients care).
participation of relatives (for instance his, her, their family).
to understand the important of the study.
Less minimal risk may occured,
Scientific requirement investigator competence,
Maintain individual welfare.
5. BENEFICIAL BENEFICENCE
Ngatidjan 26 RESEARCH ETHICS
Minimizing possible harm.
- prevent causing harm or doing wrong.
(does not do thing that is taboo).
- prevent the occuring of harm to patient and harmful publicity.
- respect to social mores (for some reason).
- sensitive to different culture
do not encounter to existing culture.
6. DO NO HARM (NONMALFICENCE)
Ngatidjan 27 RESEARCH ETHICS
6. DO NO HARM (NONMALFICENCE)
Minimizing possible harm.
inclusion criteria according to individual patient characteristic (sex, age etc.)
according to disease characteristic (severity, duration etc.)
in or out patients
exclusion criteria according to individual patient characteristic (pregnant etc.)
according to disease characteristic (severity, duration,
complicating disease, failure to response to drug etc.)
Ngatidjan 28 RESEARCH ETHICS
6. DO NO HARM (NONMALFICENCE)
Blindness masking?
to avoid bias.
may use a placebo (negative control treatment) or
standard treatment (positive control treatment)
may be as single masking, double masking or triple
masking etc.
ethical considerations?
Ngatidjan 29 RESEARCH ETHICS
Placebo involvement?
Is used when no any standard treatment for the disease.
Effective if the effect of test drug is much influenced by
subjective factor (pain, comfort etc.)
Is appropriate for mild to moderate condition of disease,
contraindicated for life threatening state of disease.
no placebo for study of infection therapy etc.
6. DO NO HARM (NONMALFICENCE)
Ngatidjan 30 RESEARCH ETHICS
ETHICAL ASPECTS OF A PROPOSAL
Aims of the study
Design of the study Methods
Treatments
Subject recruitment inclusive and exclusive subjects
vulnerable subjects
Rescue procedures
Informed consent
Confidential respondent identity IN (identity number)
Ngatidjan 31 RESEARCH ETHICS
RESEARCH MISCONDUCT
Data fabrication,
Data falsification,
Plagiarism data stealing,
or other practices that seriously deviate from those that are commonly accepted within the scientific community for
proposing, conducting and reporting research.
author involvement (for anyone who did not involve in a research or without permision),
there is no any acknowledgement to anyone who actually did most of the research work (i.e. students).
Ngatidjan 32 RESEARCH ETHICS
AGAINST ETHICS IN DOING RESEARCH
Repeat what other people did on the same topic, etc.
Stealing the idea,
Data falsification,
Submit a proposal which is (the research) had be done,
Without any informed consent (research on human),
Put someone name who is never involve in the research,
Ignore anyone who had ever contributed in the research, etc.
Ngatidjan 33 RESEARCH ETHICS
ETHICAL CLEARANCE
AND IRB (EC)
Ngatidjan 34 RESEARCH ETHICS
ETHICAL CLEARANCE
a written statement concerning the ethical property of
study on human (or animal)
issued by an IRB (institutional review board)
in the Faculty of Medicine UGM :
Komisi Etik Penelitian Kedokteran dan Kesehatan
(Medical and Health Research Ethics Committee Faculty of
Medicine Universitas Gadjah Mada RSUP Dr. Sardjito)
Ngatidjan 35 RESEARCH ETHICS
Established by an institution
which responsible for health and medical sciences
development faculty / school of medicine
The roles :
To review biomedical research for contributing and
safeguarding the dignity, rights, safety, and well-being of all
actual or potential research participants
Institutional Review Board (IRB)
Ngatidjan 36 RESEARCH ETHICS
Carrying out review of proposed research
before commencement of the research
Regular evaluation of ethics of on going
research that received a positive decision
Institutional Review Board (IRB)
Ngatidjan 37 RESEARCH ETHICS
Membership requirement
Term of appointment
Conditions of appointment
Office(s)
Quorum requirements
Independent consultants
Education of EC member
Institutional Review Board (IRB)
Ngatidjan 38 RESEARCH ETHICS
Health and medical scientists,
(At least one of) animal health practitioner,
(At least one of) law practitioner,
(At least one of) lay person.
Chairman,
Secretary,
Members.
Composition of IRB
Ngatidjan 39 RESEARCH ETHICS
Submitting an application
Reviewing
Decision making
Communication decision
Follow-up
Documentation & archiving
IRB and SOP
Ngatidjan 40 RESEARCH ETHICS
Independent and competent
ethical review is the cornerstone
for the development of health
IRB (EC) REVIEW
Ngatidjan 41 RESEARCH ETHICS
Example aspects have to be reviewed :
Scientific design and conduct of the study,
Recruitment of research participants,
Care and protection of research subjects
Protection of research participant confidentiality
Informed consent process
Community consideration
EELEMENTS OF REVIEWING
Ngatidjan 42 RESEARCH ETHICS
HOW TO GET ETHICAL CLEARANCE
1. Good written proposal of study on human (or animal)
Scientific aspect
Ethical aspect
2. Research proposal is submitted to IRB
Review it is communicated to researcher
Presentation to clarify communication
Rewrite resubmit re-review communication
3. Ethical Clearance Ngatidjan 43 RESEARCH ETHICS
Ngatidjan 44 RESEARCH ETHICS
ngatidjansp@gmail.com